Examination of the 5-ALA clinical application for gynecologic malignant tumor

Examination of the 5-ALA clinical application for gynecologic malignant tumor - Examination of the 5-ALA clinical application for gynecologic malignant tumor

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029400

Enrollment

Registered

2017-10-03

Start date

2017-10-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer, ovarian tumor

Interventions

5-aminolevulinic acid

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: surgical indication of endometrial cancer or ovarian tumor(ovarian cancer suspect)

Exclusion criteria

Exclusion criteria: 1: Allergy career; 5-aminolevulinic acid 2: A pregnant woman, a nursing woman and the patient who may be pregnant 3: The patient whom we judged to be inappropriate as a study subject

Design outcomes

Primary

Measure	Time frame
pass	—

Countries

Japan

Contacts

Public ContactYusuke Butsuhara

Kansai Medical University Department of obstetrics and gynecology

gigi1juvejp@yahoo.co.jp0728040101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026